Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AleAnna, Inc.AleAnna, Inc. Reports $4.03 Million Revenue in Q2 2025, Achieves Operating Income
Sadot Group Inc.Sadot Group Reports 34% Revenue Decline in Q2 2025, Shifts Focus to Agri-Foods
Minerva Neurosciences, Inc.Minerva Neurosciences Reports $3.3 Million Net Loss in Q2 2025, Down from $8.2 Million
SIFCO INDUSTRIES INCSIFCO Industries Reports Improved Financial Results with Reduced Net Loss and Increased Revenue
ADVANCE AUTO PARTS INCAdvance Auto Parts Reports 7.7% Decline in Q2 Sales, Restructuring Efforts Underway
Nano Nuclear Energy Inc.Nano Nuclear Energy Inc. Reports $32 Million Net Loss and $210.2 Million Cash Position in Latest 10-Q
Rein Therapeutics, Inc.Rein Therapeutics Reports Q2 2025 Financial Results with $6.8M Net Loss
AmpliTech Group, Inc.AmpliTech Group Reports 336% Revenue Growth to $11.03 Million in Q2 2025
Nuwellis, Inc.Nuwellis Reports 21.4% Decline in Q2 2025 Net Sales, Increases Losses
TAITRON COMPONENTS INCTaitron Components Reports Q2 2025 Net Loss of $327,000 Amid Restructuring Efforts
Chain Bridge IChain Bridge I Reports Net Income of $5,800 for Quarter Ending June 30, 2025
Alpha Cognition Inc.Alpha Cognition Inc. Reports $1.66 Million Revenue in Q2 2025, Despite Increased Net Loss
Vuzix CorpVuzix Reports 19% Revenue Growth in Q2 2025, Net Loss Improves by 81%
Equillium, Inc.Equillium Reports Zero Revenue and $5.7 Million Net Loss in Q2 2025
PIONEER POWER SOLUTIONS, INC.Pioneer Power Solutions Reports 146% Revenue Growth to $8.37 Million in Q2 2025
Innovative Eyewear IncInnovative Eyewear Reports 88% Revenue Growth but Faces Net Loss in Q2 2025
EMERSON RADIO CORPEmerson Radio Corp. Reports 23.8% Revenue Decline and Increased Operating Loss
BLUE DOLPHIN ENERGY COBlue Dolphin Energy Reports Q2 2025 Revenue Decline of 18.8% to $56.6 Million
Telomir Pharmaceuticals, Inc.Telomir Pharmaceuticals Reports $5.1 Million Net Loss in Q2 2025
CNS Pharmaceuticals, Inc.CNS Pharmaceuticals Reports Financial Developments and Clinical Trial Progress for Q2 2025
Yarrow Bioscience, Inc.VYNE Therapeutics Reports Q2 2025 Financial Results with Reduced Net Loss and Revenue Decline
MILESTONE SCIENTIFIC INC.Milestone Scientific Reports Q2 2025 Financial Results with $1.5M Net Loss
Appsoft Technologies, Inc.AppSoft Technologies Reports No Revenue and Increased Losses in Latest Financial Filing
ACTUATE THERAPEUTICS, INC.Actuate Therapeutics Reports $5.95 Million Net Loss in Q2 2025, Seeks Additional Capital
FLEXIBLE SOLUTIONS INTERNATIONAL INCFlexible Solutions International Reports Q2 2025 Revenue of $11.37 Million and Net Income Growth